topotecan has been researched along with Benign Supratentorial Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagiella, E; Bruce, JN; Canoll, P; DeLaPaz, RL; Fine, RL; Kennedy, BC; Lai, R; Rosenfeld, SS; Sands, SA; Surapaneni, K; Yanes, CL; Yun, J | 1 |
Díaz, MA; González-Vicent, M; Lassaletta, A; Madero, L; Pérez-Martínez, A; Sevilla, J | 1 |
Canales Ugarte, S; Cassinello Espinosa, J | 1 |
1 trial(s) available for topotecan and Benign Supratentorial Neoplasms
Article | Year |
---|---|
High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Thiotepa; Topotecan; Transplantation, Autologous; Treatment Outcome | 2005 |
2 other study(ies) available for topotecan and Benign Supratentorial Neoplasms
Article | Year |
---|---|
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan.
Topics: Adult; Aged; Attention; Convection; Drug Administration Schedule; Drug Delivery Systems; Female; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; Prospective Studies; Quality of Life; Reaction Time; Supratentorial Neoplasms; Surveys and Questionnaires; Tomography, X-Ray Computed; Topoisomerase I Inhibitors; Topotecan; Young Adult | 2011 |
Cerebral and parotid metachronous metastases from an ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Anticonvulsants; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Parotid Neoplasms; Supratentorial Neoplasms; Topotecan | 2006 |